Enhancing Human Knowledge and Capabilities with Artificial Intelligence Tools for Education Por Emerson Abraham Jackson, Hudson F. Jackson

Obter o texto integral

Metric Invariance in Exploratory Graph Analysis via Permutation Testing Por Laura Jamison, Alexander P. Christensen, Hudson F. Golino

Obter o texto integral

Clinical trials and methodological problems in prion diseases Reply Por Mead, S, Rudge, P, Hudson, F, Walker, S, Darbyshire, J, Collinge, J, Investigators, P-1

A scoping review of interventions designed to support parents with mental illness that would be appropriate for parents with psychosis Por Radley, J, Sivarajah, N, Moltrecht, B, Klampe, M-L, Hudson, F, Delahay, R, Barlow, J, Johns, LC

Analysis of Eight Rating Scales Supports the use of Functional Outcome Measures in Prion Disease Clinical Trials: Experience from the PRION-1 trial and the National Prion Monitorin... Por Mead, S, Thompson, A, Gopalakrishnan, G, Ranopa, M, Rudge, P, Wroe, S, Hudson, F, MacKay, A, Darbyshire, J, Collinge, J, Walker, S

PRION-1 scales analysis supports use of functional outcome measures in prion disease. Por Mead, S, Ranopa, M, Gopalakrishnan, G, Thompson, A, Rudge, P, Wroe, S, Kennedy, A, Hudson, F, MacKay, A, Darbyshire, J, Collinge, J, Walker, A

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Por Collinge, J, Gorham, M, Hudson, F, Kennedy, A, Keogh, G, Pal, S, Rossor, M, Rudge, P, Siddique, D, Spyer, M, Thomas, D, Walker, S, Webb, T, Wroe, S, Darbyshire, J

A randomized controlled experiment testing the use of virtual reality to trigger cigarette craving in people who smoke Por Rovira, A, Lambe, S, Beckwith, H, Ahmed, M, Hudson, F, Haynes, P, Yu, C, Williams, K, Saidel, S, Iredale, E, McBride, S, Waite, F, Pan, X, Freeman, D

Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial. Por Holodniy, M, Brown, S, Cameron, D, Kyriakides, T, Angus, B, Babiker, A, Singer, J, Owens, D, Anis, A, Goodall, R, Hudson, F, Piaseczny, M, Russo, J, Schechter, M, Deyton, L, Darbyshire, J

A randomized trial comparing concise and standard consent forms in the START trial Por Grady, C, Touloumi, G, Walker, A, Smolskis, M, Sharma, S, Babiker, A, Pantazis, N, Tavel, J, Florence, E, Sanchez, A, Hudson, F, Papadopoulos, A, Emanuel, E, Clewett, M, Munroe, D, Denning, E, START Informed Consent Substudy Group

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols Por Schiavone, F, Bathia, R, Letchemanan, K, Masters, L, Amos, C, Bara, A, Brown, L, Gilson, C, Pugh, C, Atako, N, Hudson, F, Parmar, M, Langley, R, Kaplan, RS, Parker, C, Attard, G, Clarke, NW, Gillessen, S, James, ND, Maughan, T, Sydes, MR, The Stampede And Focus4 Trial Management Group

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C Por Cooke, GS, Pett, S, McCabe, L, Jones, C, Gilson, R, Verma, S, Ryder, SD, Collier, JD, Barclay, ST, Ala, A, Bhagani, S, Nelson, M, Ch'Ng, C, Stone, B, Wiselka, M, Forton, D, McPherson, S, Halford, R, Nguyen, D, Smith, D, Ansari, A, Dennis, E, Hudson, F, Barnes, EJ, Walker, AS

Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT Por Cooke, GS, Pett, SL, McCabe, L, Jones, C, Gilson, R, Verma, S, Ryder, SD, Collier, JD, Barclay, ST, Ala, A, Bhagani, S, Nelson, M, Ch'Ng, CL, Stone, B, Wiselka, M, Forton, D, McPherson, S, Halford, R, Nguygen, D, Smith, D, Ansari, MA, Ainscough, H, Dennis, E, Hudson, F, Barnes, EJ, Walker, AS

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial Por Thwaites, GE, Scarborough, M, Szubert, AJ, Nsutebu, E, Tilley, R, Greig, J, Wyllie, SA, Wilson, P, Auckland, C, Cairns, J, Ward, D, Lal, P, Guleri, A, Jenkins, N, Sutton, J, Wilselka, M, Armando, G-R, Graham, C, Chadwick, PR, Barlow, G, Gordon, NC, Young, B, Meisner, S, McWhinney, P, Price, DA, Harvey, D, Nayar, D, Jeyaratnam, D, Planche, T, Minton, J, Hudson, F, Hopkins, S, Williams, J, Torok, ME, Llewelyn, MJ, Edgeworth, JD, Walker, AS

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT Por Thwaites, GE, Scarborough, M, Szubert, AJ, Concalves, P, Soares, M, Bostock, J, Nsutebu, E, Tilley, R, Cunningham, R, Grieg, J, Wyllie, SA, Wilson, P, Auckland, C, Cairns, J, Ward, D, Lal, P, Guleri, A, Jenkins, N, Sutton, J, Wiselka, M, Armando, G-R, Graham, C, Chadwick, PR, Barlow, G, Gordon, C, Young, B, Meisner, S, McWhinney, P, Price, DA, Harvey, D, Nayar, D, Jeyaratnam, D, Planche, T, Minton, J, Hudson, F, Hopkins, S, Williams, J, Torok, EM, Llewelyn, MJ, Edgeworth, JD, Walker, AS